isocarboxazid has been researched along with Coronary Disease in 2 studies
Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BERKMEN, R | 1 |
| KAPTANOGLU, Z | 1 |
| KURAN, S | 1 |
| MACCARINI, PA | 1 |
| AGUZZOLI, RS | 1 |
2 other studies available for isocarboxazid and Coronary Disease
| Article | Year |
|---|---|
[THERAPY OF STATUS ANGINOSUS].
Topics: Angina Pectoris; Coronary Disease; Electrocardiography; Geriatrics; Isocarboxazid; Tachycardia; Tach | 1964 |
[MONOAMINE OXIDASE INHIBITORS IN CARDIOLOGY].
Topics: Cardiology; Coronary Disease; Humans; Isocarboxazid; Monoamine Oxidase Inhibitors | 1963 |